Table 2.
Comparisons of morbidities between the postnatal growth failure (PGF) and non-postnatal growth failure (Non-PGF) groups.
| PGF (N = 1286) |
Non-PGF (N = 1513) | p-value | |
|---|---|---|---|
| RDS, n (%) | 1143 (88.9) | 949 (62.7) | 0.000 |
| Air leak, n (%), | 67 (5.2) | 24 (1.6) | 0.000 |
| Pulmonary haemorrhage, n (%) | 71 (5.5) | 26 (1.7) | 0.000 |
| PDA treatment, n (%) | 591 (46.0) | 370 (24.5) | 0.000 |
| BPD (≥moderate), n (%) | 453 (35.2) | 294 (19.4) | 0.000 |
| IVH (≥Grade 2), n (%) | 229 (17.8) | 99 (6.5) | 0.000 |
| PVL, n (%) | 127 (9.9) | 85 (5.6) | 0.000 |
| NEC, n (%) | 78 (6.1) | 18 (1.2) | 0.000 |
| Sepsis, n (%), | 326 (25.3) | 172 (11.4) | 0.000 |
| ROP (≥stage 2), n (%) | 187 (14.5) | 82 (5.4) | 0.000 |
| Congenital anomaly, n (%) | 32 (2.5) | 15 (1.0) | 0.003 |
| Duration of invasive ventilator use, d | 19.38 (23.03) | 6.71 (12.76) | 0.000 |
| Duration of oxygen use, d | 9.8 (13.96) | 7.02 (11.65) | 0.000 |
| Duration of TPN, d | 32.33 (23.75) | 16.57 (13.84) | 0.000 |
| Days reaching above 100 cc/kg of enteral nutrition | 29.44 (15.59) | 25.39 (15.17) | 0.000 |
Data are presented as numbers of patients (%) or mean (SD).
PGF, postnatal growth failure; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; BPD, bronchopulmonary dysplasia; IVH, intraventricular haemorrhage; PVL, periventricular leukomalacia; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; TPN, total parenteral nutrition.